Global Regulatory Strategies

Regulatory strategic considerations during global drug development (module 5)

Date icon
No available dates
Attendance icon

On location or online

Language icon

English

Price icon
Online 19,500 DKK ex VAT
On location 20,500 DKK ex VAT
50% discount for public institutions i
You cannot combine different discounts and offers. See our terms and conditions for more information.

Summary

As a regulatory strategist, you play an important role in the entire drug development process.


Regulatory strategy is crucial for any company that wishes to develop new and effective drugs in compliance with regulator’s expectations, while facilitating a faster and more efficient drug development process.


On this three-day course, you will examine regulatory affairs decisions and strategies closely and gain an in-depth understanding of how and why they are made.


Regulatory affairs courses typically focus on laws, guidelines, and directives, but offer little insight into the role of regulatory strategy experts within project teams.


This course takes a different approach: rather than informing about legislation and guidelines, it explores the background of global regulatory strategies and the considerations that shape them.


It also examines how the regulatory strategist works with the various stakeholders involved in developing a solid global regulatory strategy plan.


If you are an experienced regulatory affairs professional, you will benefit greatly from the insights shared by several internationally experienced lecturers in this course.


Other course participants say


"The information shared was very relevant, up to date and set in a real-world perspective. Useful course with a great team supporting a nice learning environment." 

Patrick Beke, RA Manager, Infant Bacterial Therapeutics AB


"The structure and contents were really well thought out and our course leaders and presenters were engaging and friendly."

Naja Støckel Jessen, Global Regulatory Affairs Professional, CMC, AJ Vaccines A/S

Keywords

  • Regulatory Affairs Involvement in Product Development
  • Regulatory Strategies
  • Consultation with Authorities Throughout Development
  • Regulatory Intelligence
  • The Development of a Target Label
  • Regulatory Planning
  • Intellectual Property Rights
  • Pricing and Reimbursement Negotiations 

Save information for later
Read more

Course leader & lecturers

  • Margrethe Erbou Andersen
    Course leader
    Nordic Head of Regulatory Affairs
    PharmaRelations ApS
  • Gunvor Lind Tolborg
    Course leader
    Principal Regulatory Consultant
    Pharma IT Aps
  • Daniel Brath
    Lecturer
    Market Access, Pricing and Public Affairs
    Zealth ApS
  • Sofie de Fine Licht
    Lecturer
    Medical Evidence Team Lead
    AstraZeneca A/S
  • Alma Bibuljica Sahl
    Lecturer
    Senior RA Professional
    Novo Nordisk A/S
  • Anne Louise Kirkegaard
    Lecturer

    ALK-Abelló A/S
  • Allan Dahl Rasmussen
    Lecturer
    Director, Head of Regulatory Toxicology & Safety Assessment
    H. Lundbeck A/S
  • Annette Mattsson
    Lecturer
    Vice President Regulatory Affairs
    Camurus AB
  • Britta Rosenqvist
    Lecturer
    Global Regulatory Strategy Leader, Senior Specialist
    H. Lundbeck A/S
  • Simon Suhr Borkenfelt
    Lecturer
    Senior Patent Specialist
    H. Lundbeck A/S
  • Mads Gjelstrup Kristensen
    Lecturer
    Director, Regulatory Affairs CMC
    Hemab ApS
See all

Watch the video

Is this course for you?

This course is for you if you are an experienced Regulatory Affairs professional, employed in the industry, a regulatory agency, or a consulting firm, who recently started working with regulatory strategies, or aspire to become a regulatory lead or strategist soon. To benefit from this course, you must have a solid knowledge of the legislative framework and guidelines applicable for the EU and the US.

What you will learn

  1. How to develop a global regulatory strategy for products in various stages of the product life cycle
  2. How to analyse strengths and weaknesses of a product when developing a regulatory strategy and a target label
  3. What the various stakeholders involved in the development of a regulatory strategy are
  4. The roles and deliverables of a regulatory strategist operating in a dynamic environment, to ensure the regulatory strategy meets the needs of internal and external business partners and health authorities

What your company will get

  1. A regulatory affairs professional who can play an active and effective role in the entire drug development process
  2. A regulatory affairs professional who can develop a global regulatory strategy for products in various stages of the product life cycle
  3. A regulatory affairs professional who can manage the complex environment and many stakeholders involved in the development and execution of a regulatory strategy
  4. A regulatory affairs professional who understands the roles and responsibilities of a regulatory strategist

Course information

Literature

Prior to the course you will receive information about mandatory and optional readings. You are expected to familiarise yourself with the mandatory readings before starting the course. These readings are also a part of the examination syllabus.

Prerequisites

To enroll in this course, you must have a relevant educational background at bachelor level or higher and be experienced within regulatory affairs. It is a benefit to have completed the courses “EU Pharmaceutical Framework & Approvals” and “The US Regulatory Environment” before joining this course. Alternatively, have knowledge of Regulatory Affairs at a level similar to what is being taught on these courses.


If you do not fulfil the requirements, you can still apply if you have experience in the pharmaceutical or biological area that would allow you to benefit from the training and enable you to participate actively during the module. Up to 10% of positions are filled by applicants with no or limited experience in regulatory affairs. We consider all applications on a case-by-case basis.

Examination

The exam is held online, usually 4-6 weeks after the course.

You will receive a link with exam questions via your personal Atrium log-in.

In order to participate in the exam, you must have attended the course.

This course is a part of a diploma

Diploma in Regulatory Affairs

The regulatory affairs diploma gives you an understanding of the entire regulatory affairs platform of the medicinal lifecycle. All courses have been designed in collaboration with highly acclaimed experts that are on our regulatory affairs Advisory Board.

Read more

Course leaders

Margrethe Erbou Andersen
Nordic Head of Regulatory Affairs
PharmaRelations ApS
Gunvor Lind Tolborg
Principal Regulatory Consultant
Pharma IT Aps

Lecturers

Daniel Brath
Market Access, Pricing and Public Affairs
Zealth ApS
Sofie de Fine Licht
Medical Evidence Team Lead
AstraZeneca A/S
Alma Bibuljica Sahl
Senior RA Professional
Novo Nordisk A/S
Anne Louise Kirkegaard

ALK-Abelló A/S
Allan Dahl Rasmussen
Director, Head of Regulatory Toxicology & Safety Assessment
H. Lundbeck A/S
Annette Mattsson
Vice President Regulatory Affairs
Camurus AB
Britta Rosenqvist
Global Regulatory Strategy Leader, Senior Specialist
H. Lundbeck A/S
Simon Suhr Borkenfelt
Senior Patent Specialist
H. Lundbeck A/S
Mads Gjelstrup Kristensen
Director, Regulatory Affairs CMC
Hemab ApS

You may also be interested in these courses

Want to know more or need help?

Contact Client Manager Christina Spangsberg at +45 39 15 09 22

Send me a message